Understanding the Tip:
Why sedimentation and redispersibility matter in suspension products:
Suspensions are inherently unstable systems where solid particles settle over time due to gravity. The extent of sedimentation and the ease with which the sediment can be redispersed determine the usability and dose uniformity of the product. If sediment becomes compacted (caking) or resistant to resuspension, it may compromise product efficacy, safety, or patient compliance.
Risks associated with poor redispersibility:
Products that require excessive shaking, fail to redisperse uniformly, or display irreversible sedimentation may deliver variable doses. This is especially problematic for pediatric, geriatric, or narrow-therapeutic-index drugs. During stability studies, if physical changes in suspension are not monitored, the risk of batch failures, complaints, or recalls increases significantly.
Regulatory and Technical Context:
ICH, WHO, and pharmacopoeial guidance on suspension stability:
ICH Q1A(R2) recommends evaluation of physical attributes, including appearance and uniformity, during stability studies. WHO TRS 1010 and USP emphasize visual and mechanical assessment of suspensions for sedimentation and redispersibility. Regulatory submissions (CTD Module 3.2.P.5 and 3.2.P.8.3) must include evidence that suspensions remain physically stable and re-suspendable under storage conditions.
Expectations during audits and inspections:
Auditors often review physical stability data for suspensions across all time points. If sedimentation patterns vary or redispersibility becomes poor, they may
Best Practices and Implementation:
Design appropriate sedimentation and redispersibility protocols:
Establish visual and mechanical assessment protocols at each stability pull point. Evaluate:
- Extent of sedimentation (e.g., sedimentation volume ratio, height of sediment)
- Ease of redispersion (number of inversions required)
- Presence of caking or hard packing
- Clarity and uniformity after shaking
Perform evaluations in triplicate and document results with reference photographs for each batch and time point.
Define acceptance criteria and scoring systems:
Set clear, pre-approved limits for acceptable sedimentation and redispersion. For example:
- Redispersion in ≤10 inversions
- No visible lumps or cake formation
- Suspension appears uniform after shaking
Use scoring systems (e.g., 1–5 scale) to quantify physical changes and identify trends before they become specification failures.
Integrate physical stability checks into regulatory reports:
Include sedimentation and redispersion data in CTD Module 3.2.P.8.3 with photographic evidence or trend charts. If changes are observed, discuss formulation strategies to mitigate risks (e.g., use of structured vehicles, flocculating agents, or surfactants). Also reference findings in Annual Product Quality Reviews (PQRs) and use them to guide formulation or packaging changes.
Ensure that labeling includes clear instructions for shaking and resuspension to align with real-world observations during stability testing.